STOCK TITAN

ZIMVIE INC SEC Filings

ZIMV Nasdaq

Welcome to our dedicated page for ZIMVIE SEC filings (Ticker: ZIMV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

This page provides access to historical SEC filings for ZimVie Inc. (formerly Nasdaq: ZIMV), which reported itself as a global life sciences leader in the dental and dental implant market. While ZimVie was a public company, it filed current reports, periodic reports, and proxy materials with the U.S. Securities and Exchange Commission that documented its financial performance, corporate actions, and the details of its acquisition by an affiliate of ARCHIMED.

Key filing types for ZimVie include Form 8-K current reports describing material events. For example, a July 21, 2025 Form 8-K outlines the Agreement and Plan of Merger with Zamboni Parent Inc. and Zamboni MergerCo Inc., an affiliate of ARCHIMED, including the cash consideration per share and the conditions to closing. Subsequent 8-K filings on October 3 and October 10, 2025 provide information on supplemental proxy disclosures, stockholder litigation related to the proxy statement, and the results of the special meeting at which stockholders voted to adopt the merger agreement.

Another Form 8-K dated July 30, 2025 incorporates a press release reporting financial results for the quarter ended June 30, 2025. This filing discusses net sales from continuing operations, net loss from continuing operations, adjusted EBITDA, and adjusted diluted earnings per share, and explains the use of non-GAAP financial measures and constant currency sales metrics. Earlier filings and related documents, such as annual reports on Form 10-K and quarterly reports on Form 10-Q referenced in company news releases, contain more detailed financial statements, risk factors, and management’s discussion and analysis.

Filings around the merger also describe the expected delisting and deregistration of ZimVie’s common stock. The October 10, 2025 Form 8-K notes that, upon completion of the merger, the company would no longer be publicly held, and its common stock would be delisted from the Nasdaq Global Select Market and deregistered under the Securities Exchange Act of 1934. A later company press release confirms that, after the closing of the transaction on October 20, 2025, ZimVie became a privately held company and its stock ceased trading on Nasdaq.

On this page, users can review these historical filings to trace ZimVie’s regulatory history, including its financial reporting practices, the structure and terms of the ARCHIMED acquisition, and disclosures related to stockholder litigation and proxy processes. AI-powered summaries can help explain the main points of each filing, highlight important sections in lengthy documents, and make it easier to understand how ZimVie’s public-company obligations evolved up to its transition to private ownership.

Rhea-AI Summary

ZimVie Inc. (ZIMV): insider transaction tied to merger closing. Indraneel Kanaglekar, Senior Vice President and Chief Commercial Officer, reported the disposition of common stock and equity awards in connection with the closing of the merger on October 20, 2025, when Zamboni MergerCo Inc. merged into ZimVie, making it a wholly owned subsidiary of Zamboni Parent Inc.

Each share of ZimVie common stock converted into the right to receive $19.00 in cash at the effective time. The filing shows 63,438 shares disposed and a resulting beneficial ownership of 0 shares. In addition, 121,897 restricted stock units vested in full at closing and were canceled for a cash payment equal to the number of underlying shares multiplied by $19.00, subject to withholding. The footnotes also note 588 shares acquired under the Employee Stock Purchase Plan on September 30, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

ZimVie Inc. (ZIMV) director reports merger-related cash-out. On 10/20/2025, in connection with the closing of the merger with Zamboni Parent Inc., all ZimVie common shares and certain equity awards held by Director Sally Crawford were converted into the right to receive cash.

Each share of common stock was converted into $19.00 per share in cash at the effective time. The filing shows the disposition of 40,127 common shares. In addition, 6,755.864 deferred share units and 57,728 restricted stock units vested in full and were canceled for a cash amount based on the same $19.00 per-share consideration, subject to applicable withholding.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

ZimVie Inc. (ZIMV) reported an insider transaction tied to its merger. On October 20, 2025, the company completed a merger under which each share of common stock was converted into the right to receive $19.00 in cash. In this Form 4, Chief Accounting Officer Sandra Schneider reported the disposition of 40,794 shares of common stock and now holds 0 shares.

All outstanding restricted stock units vested at the effective time and were canceled for cash based on the same $19.00 per-share consideration. Schneider’s 49,956 RSUs were settled in cash and now total 0 derivative securities. Following the merger, ZimVie became a wholly owned subsidiary of Zamboni Parent Inc.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

ZimVie Inc. (ZIMV) reported an insider Form 4 reflecting completion of a merger effective on October 20, 2025. At the effective time, each share of ZimVie common stock was converted into the right to receive $19.00 in cash, and all such shares were canceled.

The filing shows equity awards held by director Vinit Asar were settled in cash per the merger terms. Deferred Share Units totaling 8,289.986 and Restricted Stock Units totaling 57,728 vested in full and were canceled, with the cash amount based on the $19.00 per-share merger consideration. The company accelerated unvested awards immediately prior to the effective time as required by the merger agreement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

ZimVie Inc. (ZIMV) completed a merger on October 20, 2025, after which each share of common stock was converted into the right to receive $19.00 in cash. All common shares ceased to be outstanding at the effective time.

For director Karen Matusinec, 6,755.864 deferred share units and 57,728 restricted stock units vested and were canceled, each converting into a cash payment equal to the number of underlying shares multiplied by $19.00. Following these transactions, the Form 4 reports 0 derivative securities beneficially owned.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

ZimVie (ZIMV) insider filing: Executive Vice President, Chief Financial Officer and Treasurer Richard Heppenstall reported the disposition of 125,389 shares of common stock on 10/20/2025, tied to the completion of a cash merger. Each share was converted into the right to receive $19.00 in cash, and all shares were canceled as ZimVie became a wholly owned subsidiary of Zamboni Parent Inc.

Additionally, 227,851 restricted stock units vested at the effective time and were canceled for a cash payment equal to the number of units multiplied by $19. The company accelerated vesting of Mr. Heppenstall’s unvested equity awards as required by the merger agreement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

ZimVie (ZIMV) insider filing: President and CEO Vafa Jamali reported merger-related transactions dated October 20, 2025. In connection with the closing of the merger with Zamboni Parent Inc. and Zamboni MergerCo Inc., each share of ZimVie common stock was converted into the right to receive $19.00 in cash, without interest and subject to tax withholding.

Jamali reported the disposition of common stock and showed 0 shares owned directly after the transaction. The filing also notes prior acquisition of 1,682 shares under the Employee Stock Purchase Plan on May 30, 2025. Additionally, 786,541 restricted stock units vested in full at the Effective Time and were canceled for a cash payment based on the $19.00 per share merger consideration.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

ZimVie Inc. completed a cash merger on October 20, 2025, in which each share of common stock was converted into the right to receive $19.00 in cash. Following the closing, all common shares were canceled and ZimVie became a wholly owned subsidiary of the acquirer.

For director Richard Kuntz, 13,072.965 deferred share units and 57,728 restricted stock units vested at the effective time and were canceled for a cash payment calculated as the number of underlying shares multiplied by the $19.00 per-share merger consideration.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

ZimVie (ZIMV): Senior VP and Corporate Secretary Heather Kidwell reported a merger-related disposition of company equity. On October 20, 2025, 83,674 shares of common stock were converted into the right to receive $19.00 per share in cash upon the merger’s closing. Following the effective time, all such shares were canceled.

The filing also notes that 149,190 restricted stock units vested in full at closing and were canceled for a cash payment based on the same $19.00 per-share merger consideration, as provided in the Merger Agreement. ZimVie became a wholly owned subsidiary of the acquirer at closing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

ZimVie Inc. entered into an Agreement and Plan of Merger with Zamboni Parent Inc. and its wholly owned MergerCo, under which MergerCo will merge into ZimVie and ZimVie will become a wholly owned subsidiary of Parent. As a result, ZimVie will cease to be publicly held and its common stock will be delisted from the Nasdaq Global Select Market and deregistered under the Exchange Act. A special meeting of stockholders was held on October 10, 2025 to vote on proposals disclosed in the definitive proxy filed on September 2, 2025. Stockholders approved the Merger Agreement Proposal and also approved the advisory (non-binding) compensation proposal. An adjournment proposal was not submitted because there were sufficient votes to approve the Merger Agreement Proposal at the meeting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.16%
Tags
current report

FAQ

What is the current stock price of ZIMVIE (ZIMV)?

The current stock price of ZIMVIE (ZIMV) is $18.99 as of October 18, 2025.

What is the market cap of ZIMVIE (ZIMV)?

The market cap of ZIMVIE (ZIMV) is approximately 535.7M.
ZIMVIE INC

Nasdaq:ZIMV

ZIMV Rankings

ZIMV Stock Data

535.72M
27.24M
2.73%
90.92%
2.64%
Medical Devices
Dental Equipment & Supplies
Link
United States
PALM BEACH GARDEN

ZIMV RSS Feed